MILIND JAVLE to Radiation-Sensitizing Agents
This is a "connection" page, showing publications MILIND JAVLE has written about Radiation-Sensitizing Agents.
Connection Strength
0.289
-
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021 10; 6(10):803-815.
Score: 0.170
-
The role of PARP in DNA repair and its therapeutic exploitation. Br J Cancer. 2011 Oct 11; 105(8):1114-22.
Score: 0.086
-
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2017 Nov 01; 152(11):1048-1056.
Score: 0.033